-transparent.png){kind=logo}
A double-blind comparative study of 1 alpha-OHD3 and placebo was performed on 37 patients with osteoporotic hip fracture without clinical osteomalacia. 1 alpha-OHD3, in a dose of 1 microgram/day together with 2.5 g CaCO3, did not heal osteoporosis as judged from determinations of bone mineral density and histomorphometric analyses during four months of treatment. However, 1 alpha-OHD3 seemed to have an effect on fracture healing as concluded from the posttreatment alkaline phosphatase level. Hypercalcemia was common, occurring in six out of 19 patients treated with 1 alpha-OHD3. It is concluded that treatment of osteoporosis with 1 alpha-OHD3 and calcium is ineffective and potentially dangerous because it frequently causes hypercalcemia.
V Hoikka, and
E M Alhava, and
A Aro, and
P Karjalainen, and
V Rehnberg
January 1979,
Scandinavian journal of rheumatology,
V Hoikka, and
E M Alhava, and
A Aro, and
P Karjalainen, and
V Rehnberg
June 1978,
Polskie Archiwum Medycyny Wewnetrznej,
V Hoikka, and
E M Alhava, and
A Aro, and
P Karjalainen, and
V Rehnberg
February 1977,
British medical journal,
V Hoikka, and
E M Alhava, and
A Aro, and
P Karjalainen, and
V Rehnberg
February 1979,
Clinical science (London, England : 1979),
V Hoikka, and
E M Alhava, and
A Aro, and
P Karjalainen, and
V Rehnberg
April 1985,
Endocrinologia japonica,
V Hoikka, and
E M Alhava, and
A Aro, and
P Karjalainen, and
V Rehnberg
July 1976,
Harefuah,
V Hoikka, and
E M Alhava, and
A Aro, and
P Karjalainen, and
V Rehnberg
January 1982,
Revista clinica espanola,
V Hoikka, and
E M Alhava, and
A Aro, and
P Karjalainen, and
V Rehnberg
May 1977,
Calcified tissue research,
V Hoikka, and
E M Alhava, and
A Aro, and
P Karjalainen, and
V Rehnberg
October 1976,
British medical journal,
V Hoikka, and
E M Alhava, and
A Aro, and
P Karjalainen, and
V Rehnberg
May 1977,
Calcified tissue research,
